fumonisin b1

fumonisin b1 is a lipid of Sphingolipids (SP) class. Fumonisin b1 is associated with abnormalities such as Infection, Kidney Diseases, Liver diseases, DERMATITIS HERPETIFORMIS, FAMILIAL and Malnutrition. The involved functions are known as Gene Expression, Anabolism, Signal, Biosynthetic Pathways and Regulation. Fumonisin b1 often locates in Body tissue, Microsomes, microsomal membrane, Protoplasm and Mitochondria. The associated genes with fumonisin b1 are Genome, P4HTM gene, FATE1 gene, BCL2 gene and TMEM132D gene. The related lipids are dihydroceramide, ceramide 1-phosphate, Sphingolipids, Fatty Acids and Palmitates.

Cross Reference

Introduction

To understand associated biological information of fumonisin b1, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with fumonisin b1?

fumonisin b1 is suspected in Infection, Kidney Diseases, Liver diseases, DERMATITIS HERPETIFORMIS, FAMILIAL, Malnutrition, Celiac Disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with fumonisin b1

MeSH term MeSH ID Detail
Pseudorabies D011557 1 associated lipids
Adenoma, Liver Cell D018248 2 associated lipids
Neuroectodermal Tumors, Primitive, Peripheral D018241 3 associated lipids
Paralysis D010243 4 associated lipids
Neural Tube Defects D009436 5 associated lipids
Neuronal Ceroid-Lipofuscinoses D009472 5 associated lipids
Hydrocephalus D006849 6 associated lipids
Scrapie D012608 7 associated lipids
Pasteurella Infections D010326 8 associated lipids
Cleft Palate D002972 9 associated lipids
Magnesium Deficiency D008275 9 associated lipids
Salmonella Infections, Animal D012481 9 associated lipids
Death, Sudden D003645 12 associated lipids
Gaucher Disease D005776 13 associated lipids
Stomatitis D013280 14 associated lipids
Fetal Resorption D005327 15 associated lipids
Testicular Diseases D013733 15 associated lipids
Swine Diseases D013553 16 associated lipids
Choline Deficiency D002796 16 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Mycoses D009181 18 associated lipids
Carcinoma D002277 18 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Poultry Diseases D011201 21 associated lipids
Pulmonary Edema D011654 23 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Glioblastoma D005909 27 associated lipids
Brain Diseases D001927 27 associated lipids
Kidney Neoplasms D007680 29 associated lipids
Kidney Diseases D007674 29 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Hyperplasia D006965 34 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Nervous System Diseases D009422 37 associated lipids
Lung Diseases D008171 37 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Adenoma D000236 40 associated lipids
Liver Neoplasms, Experimental D008114 46 associated lipids
Fatty Liver D005234 48 associated lipids
Precancerous Conditions D011230 48 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Asthma D001249 52 associated lipids
Neuroblastoma D009447 66 associated lipids
Stomach Ulcer D013276 75 associated lipids
Seizures D012640 87 associated lipids
Weight Gain D015430 101 associated lipids
Glioma D005910 112 associated lipids
Inflammation D007249 119 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 54

PubChem Associated disorders and diseases

What pathways are associated with fumonisin b1

Lipid pathways are not clear in current pathway databases. We organized associated pathways with fumonisin b1 through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with fumonisin b1?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with fumonisin b1?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with fumonisin b1?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with fumonisin b1?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with fumonisin b1?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with fumonisin b1

Download all related citations
Per page 10 20 50 100 | Total 1278
Authors Title Published Journal PubMed Link
Beier RC et al. Calculated three dimensional structures of the fumonisin B1-4 mycotoxins. 1995 Bull Environ Contam Toxicol pmid:7767023
Pósa R et al. Interaction of Bordetella bronchiseptica, Pasteurella multocida, and fumonisin B1 in the porcine respiratory tract as studied by computed tomography. 2011 Can. J. Vet. Res. pmid:22210993
Park MA et al. Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation. 2008 Cancer Biol. Ther. pmid:18787411
Abnet CC et al. Sphingolipids as biomarkers of fumonisin exposure and risk of esophageal squamous cell carcinoma in china. 2001 Cancer Causes Control pmid:11714110
Voss KA et al. Carcinogenicity and mechanism of action of fumonisin B1: a mycotoxin produced by Fusarium moniliforme (= F. verticillioides). 2002 Cancer Detect. Prev. pmid:12088196
van der Westhuizen L et al. Fumonisin B1 as a urinary biomarker of exposure in a maize intervention study among South African subsistence farmers. 2011 Cancer Epidemiol. Biomarkers Prev. pmid:21266524
Gong YY et al. Association between tortilla consumption and human urinary fumonisin B1 levels in a Mexican population. 2008 Cancer Epidemiol. Biomarkers Prev. pmid:18349288
Gelderblom WC et al. Cancer initiation by fumonisin B(1) in rat liver--role of cell proliferation. 2001 Cancer Lett. pmid:11431101
Gelderblom WC et al. The cancer-promoting potential of fumonisin B1 in rat liver using diethylnitrosamine as a cancer initiator. 1996 Cancer Lett. pmid:9020908
Sahu SC et al. Peroxidation of membrane lipids and oxidative DNA damage by fumonisin B1 in isolated rat liver nuclei. 1998 Cancer Lett. pmid:9566705
Lemmer ER et al. The effects of dietary iron overload on fumonisin B1-induced cancer promotion in the rat liver. 1999 Cancer Lett. pmid:10656628
Takasaki M et al. Cancer chemopreventive activity of euglobal-G1 from leaves of Eucalyptus grandis. 2000 Cancer Lett. pmid:10814880
Mehta R et al. Glutathione S-transferase-placental form expression and proliferation of hepatocytes in fumonisin B1-treated male and female Sprague-Dawley rats. 1998 Cancer Lett. pmid:9652790
Blázquez C et al. Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas. 2004 Cancer Res. pmid:15313899
Wang XZ et al. Aberrant sphingolipid signaling is involved in the resistance of prostate cancer cell lines to chemotherapy. 1999 Cancer Res. pmid:10582708
Huang C et al. Repression of protein kinase C and stimulation of cyclic AMP response elements by fumonisin, a fungal encoded toxin which is a carcinogen. 1995 Cancer Res. pmid:7712470
Garzotto M et al. 12-O-tetradecanoylphorbol-13-acetate-induced apoptosis in LNCaP cells is mediated through ceramide synthase. 1998 Cancer Res. pmid:9605775
Blázquez C et al. Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression. 2008 Cancer Res. pmid:18339876
Pinelli E et al. Activation of mitogen-activated protein kinase by fumonisin B(1) stimulates cPLA(2) phosphorylation, the arachidonic acid cascade and cAMP production. 1999 Carcinogenesis pmid:10469611
Ramljak D et al. A potential mechanism for fumonisin B(1)-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3beta activity. 2000 Carcinogenesis pmid:10910956